HOME > TOP STORIES

TOP STORIES

BUSINESS Novartis Adds LABA/LAMA Combination Ultibro to Lineup of Breezhaler Products for COPD Using the Same Inhaler

January 24, 2014
REGULATORY DPP-4 Inhibitors, Remicade to Face Market Expansion Re-Pricing in FY2014 Revision

January 23, 2014
BUSINESS Azilva Remains No.1 in December “Mind Share” Ranking in GP, HP Markets

January 22, 2014
BUSINESS Sales Reps Vied over Questionnaire Transfers in Tasigna Trial, Boss OK’ed Incentive Program: Novartis

January 21, 2014
BUSINESS Novartis Sales Reps Transferred Patient Questionnaires in Investigator-Led Trial

January 20, 2014
BUSINESS Japan’s First SGLT-2 Inhibitor Suglat Approved: Astellas

January 20, 2014
REGULATORY More Manpower, Knowledge Necessary for Giving New Drugs World’s First Approval: PMDA Chief Executive

January 17, 2014
REGULATORY Varicella, Adult Pneumococcal Vaccines to Join Japan’s Routine Immunization Program in October

January 16, 2014
ORGANIZATION Generic Makers Likely to Disclose Payments to Medical Institutions from Early May

January 15, 2014
ORGANIZATION JPWA Chair Weighs Cartel Deal to Unify Tax Display Methods after Sales Levy Hike

January 14, 2014
REGULATORY Did Novartis Employees “Willfully” Use Rigged Data in Diovan Ads? Statute of Limitations Will Pose Hurdles to Chase Key Figure

January 10, 2014
ORGANIZATION Next Drug Price Revision Won’t Help Promote Generic Use, JGA President Says

January 9, 2014
REGULATORY MHLW Files Criminal Complaint against Novartis over Diovan Ads

January 9, 2014
BUSINESS Former Pfizer EPBU Head Matsumori Joins SBI Biotech as President

January 8, 2014
REGULATORY MHLW to File Criminal Complaint against Novartis Jan. 8

January 8, 2014
REGULATORY MHLW Economic Affairs Official Says Shakeout in Generic Sphere “Inevitable”

January 7, 2014
BUSINESS New Price Cut Rule for Long-Listed Products Blow to Drug Makers

January 6, 2014
ORGANIZATION New Price Cut for Long-Listed Products “Harsh,” Needs Follow-Up Review: FPMAJ Chair Naito

January 1, 2014
BUSINESS Takeda to End Development of TAK-875 Due to Liver Safety Concerns

December 27, 2013
BUSINESS Nissan Chemical Sues Seven Generic Companies over Livalo Patents

December 27, 2013

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo Backs Draft FY2026 Pricing Reform Outline, Rejects Key Industry Requests

By Takashi Ebisawa

The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…

COLUMN

AI: Your New HR BFF (Not Your Replacement!)

By Philip Carrigan

Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…

COMMENTARY

Radioligand Therapy Faces Capacity Bottleneck in Japan, System Build-Out Needed to Deliver on Promise

By Koji Shimomura

Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…